Asia Pacific Artificial Cervical Intervertebral Disc Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Material (Biopolymer Material and Metal Material) and End User (Hospitals, Ambulatory Surgical Centers, and Others)

The artificial cervical intervertebral disc market in Asia Pacific is expected to grow from US$ 369.24 million in 2022 to US$ 1,023.15 million by 2028. It is estimated to grow at a CAGR of 18.5% from 2021 to 2028.

With increasing manufacturing costs, medical device manufacturers struggle to generate enough revenue to please their investors. The emerging markets in developing economies are crucial in offering better and more lucrative growth opportunities to major players to expand their business and geographic reach. The treatment of orthopedic conditions has become simpler with the help of advanced medical technologies. Minimally invasive surgeries such as artificial cervical intervertebral disc replacement surgery have reduced the consumption of heavy-dose medicines. The adoption of these orthopedic surgeries is likely to increase in Asia Pacific.

The investment in the healthcare sector is more in Asia Pacific. Governments in this region are aggressively creating awareness regarding minimally invasive orthopedic surgeries through various initiatives. The healthcare expenditure in economies, such as India, China, and others, is growing, which has created many opportunities, thereby providing better services. These countries are witnessing an increase in adult and geriatric populations. Therefore, the incidences of orthopedic conditions are likely to increase. Also, there is a rise in the number of start-up companies operating in healthcare sectors in countries such as India and China.

In addition, the availability of technologically advanced infrastructure is likely to boost the local players in manufacturing advanced orthopedic products. Therefore, the market in developing countries is likely to show high growth potential over the next few years.

 Asia Pacific Artificial Cervical Intervertebral Disc Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Artificial Cervical Intervertebral Disc Market Segmentation       

The Asia Pacific artificial cervical intervertebral disc market is analyzed on the basis of material, end user, and country. Based on material, the market has been bifurcated into biopolymer and metal. In 2022, the biopolymer material segment held a larger market share. Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and others. In 2022, the hospitals segment held the largest market share.

Based on country, the Asia Pacific market is fragmented into Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific. China will hold the largest market share by the end of 2022.

B. Braun Melsugen AG.; Globus Medical, Inc.; Medtronic; NuVasive, Inc.; Orthofix Medical, Inc.; and Zimmer Biomet Holdings, Inc. are the leading companies in the Asia Pacific artificial cervical intervertebral disc market.

1. B. Braun Melsugen AG.

2. Globus Medical, Inc.

3. Medtronic

4. NuVasive, Inc.

5. Orthofix Medical, Inc.

6. Zimmer Biomet Holdings, Inc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific Artificial Cervical Intervertebral Disc Market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Artificial Cervical Intervertebral Disc Market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Artificial Cervical Intervertebral Disc Market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution